Literature DB >> 2291516

Mechanisms of anticancer activities of adenine nucleotides in tumor-bearing hosts.

E Rapaport1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2291516     DOI： 10.1111/j.1749-6632.1990.tb37668.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

Review 2.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

3.  Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines.

Authors:  Eliezer Rapaport; Anna Salikhova; Edward H Abraham
Journal:  Purinergic Signal       Date:  2015-04-29       Impact factor: 3.765

Review 4.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

5.  Extracellular nucleotides stimulate proliferation in MCF-7 breast cancer cells via P2-purinoceptors.

Authors:  C J Dixon; W B Bowler; P Fleetwood; A F Ginty; J A Gallagher; J A Carron
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors.

Authors:  K Maaser; M Höpfner; H Kap; A P Sutter; B Barthel; B von Lampe; M Zeitz; H Scherübl
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

7.  Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling.

Authors:  D Avanzato; T Genova; A Fiorio Pla; M Bernardini; S Bianco; B Bussolati; D Mancardi; E Giraudo; F Maione; P Cassoni; I Castellano; L Munaron
Journal:  Sci Rep       Date:  2016-09-02       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.